Spero Therapeutics
Peter Castrichini is an experienced finance professional currently serving as Associate Director and Assistant Controller at Spero Therapeutics since January 2024. Prior to this role, Peter held the position of Associate Director and Assistant Controller at Homology Medicines, Inc. from June 2019 to December 2023. Peter also worked as a Senior Accountant at Organogenesis from July 2017 to June 2019 and at O'Connor & Drew, P.C. from August 2013 to July 2017. Peter earned a Bachelor of Science in Business Administration with a focus on Accounting from Stonehill College and a Master's degree in Accounting from Babson College. Peter completed high school at Concord Carlisle Regional High School.
This person is not in any teams
This person is not in any offices
Spero Therapeutics
2 followers
Spero Therapeutics (Nasdaq: SPRO) is a multi-asset pre-commercial stage biopharmaceutical company in Cambridge, Mass. We are highly committed to advancing novel treatment approaches for bacterial infections with a world-class team of biotechnological and biopharmaceutical experts. The company has a pipeline of novel and highly differentiated antibacterial and rare disease product candidates focused on patients' unmet needs with multi-drug resistant (MDR) bacterial infections.